Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study

[1] Gunawardena H(2009)Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression Rheumatology 48 607-612

[2] Betteridge ZE(2009)RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease Arthritis Rheum 60 2193-2200

[3] McHugh NJ(2010)The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody Rheumatology 49 433-440

[4] Sato S(2012)Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis Rheumatology 51 1563-1570

[5] Hoshino K(2012)The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM Rheumatology 51 1278-1284

[6] Satoh T(2011)The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study J Am Acad Dermatol 65 25-34

[7] Fujita T(2012)Adult and juvenile dermatomyositis patients with anti-MDA5 autoantibodies [abstract] Arthritis Rheum 64 S715-1315

[8] Kawakami Y(2013)Anti-MDA5-associated dermatomyositis: Expanding the clinical spectrum Arthritis Care Res 65 1307-677

[9] Fujita T(2011)Anti-Melanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis J Pediatr 158 675-675

[10] Kuwana M(2012)Clinical Utility of Anti-CADM-140/Melanoma differentiation-associated gene 5 autoantibody titres in patients with juvenile dermatomyositis and rapidly progressive interstitial lung disease [abstract] Arthritis Rheum 64 S128-374

[1] Gunawardena H(2009)Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression Rheumatology 48 607-612

[2] Betteridge ZE(2009)RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease Arthritis Rheum 60 2193-2200

[3] McHugh NJ(2010)The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody Rheumatology 49 433-440

[4] Sato S(2012)Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis Rheumatology 51 1563-1570

[5] Hoshino K(2012)The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM Rheumatology 51 1278-1284

[6] Satoh T(2011)The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study J Am Acad Dermatol 65 25-34

[7] Fujita T(2012)Adult and juvenile dermatomyositis patients with anti-MDA5 autoantibodies [abstract] Arthritis Rheum 64 S715-1315

[8] Kawakami Y(2013)Anti-MDA5-associated dermatomyositis: Expanding the clinical spectrum Arthritis Care Res 65 1307-677

[9] Fujita T(2011)Anti-Melanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis J Pediatr 158 675-675

[10] Kuwana M(2012)Clinical Utility of Anti-CADM-140/Melanoma differentiation-associated gene 5 autoantibody titres in patients with juvenile dermatomyositis and rapidly progressive interstitial lung disease [abstract] Arthritis Rheum 64 S128-374